文献速递创伤与烧伤儿科与产科急症

PECARN预测规则的多中心外部验证:识别需要急性干预的腹腔内损伤极低风险儿童

Multicenter external validation of the Pediatric Emergency Care Applied Research Network rule to identify children at very low risk for intra-abdominal injury requiring acute intervention.
PubMed 文献 · J Trauma Acute Care Surg · 2025-04-02
一句话结论PECARN规则对需要急性干预的腹腔内损伤阴性预测值99.8%,但漏诊部分有临床影响的腹腔内损伤,作者建议联合创伤 bay 实验室检查和胸部X线预测所有腹腔内损伤的极低风险。

本研究前瞻性收集14个创伤中心1年内2188例16岁以下钝性腹部创伤儿童数据,回顾性应用PECARN预测规则进行风险分层。规则识别62例需急性干预腹腔内损伤中的60例,敏感度96.8%、特异度46.6%、阴性预测值99.8%;识别261例任何腹腔内损伤中的227例,敏感度86.6%、特异度49.7%、阴性预测值96.5%。最常漏诊的损伤为肝裂伤(n=22)。35例未被规则预测的腹腔内损伤患者中34例有异常实验室值或X线发现。作者认为规则对需急性干预损伤阴性预测值极佳,但漏诊部分有临床影响的损伤,建议联合创伤 bay 实验室检查和胸部X线预测所有腹腔内损伤的极低风险。

要点

  • PECARN规则识别需急性干预腹腔内损伤的敏感度96.8%、特异度46.6%、阴性预测值99.8%(62例中识别60例)。
  • PECARN规则识别任何腹腔内损伤的敏感度86.6%、特异度49.7%、阴性预测值96.5%(261例中识别227例)。
  • 规则最常漏诊的损伤为肝裂伤(n=22)。
  • 35例未被规则预测的腹腔内损伤患者中34例有异常实验室值或X线发现,作者建议联合创伤 bay 实验室检查和胸部X线预测所有腹腔内损伤的极低风险。
  • 研究为前瞻性收集14个创伤中心2188例16岁以下钝性腹部创伤儿童数据后回顾性应用规则,证据等级为治疗/临床管理 Level III。

适用人群与场景

  • 14个创伤中心前瞻性收集的2188例16岁以下钝性腹部创伤儿童,平均(标准差)年龄7.8(4.6)岁,观察期1年。

研究设计与关键结果

  • 研究类型:前瞻性收集数据后回顾性应用PECARN预测规则进行风险分层,14个创伤中心,2188例16岁以下钝性腹部创伤儿童,平均(标准差)年龄7.8(4.6)岁,观察期1年。
  • PECARN规则识别需急性干预腹腔内损伤:62例中识别60例,敏感度96.8%、特异度46.6%、阴性预测值99.8%。
  • PECARN规则识别任何腹腔内损伤:261例中识别227例,敏感度86.6%、特异度49.7%、阴性预测值96.5%。
  • 规则最常漏诊的损伤为肝裂伤(n=22)。
  • 35例未被规则预测的腹腔内损伤患者中34例有异常实验室值或X线发现。

证据类型、等级与局限

  • 证据类型:多中心外部验证研究(前瞻性数据收集、回顾性应用规则);证据等级:治疗/临床管理 Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,PECARN规则对识别需要急性干预的腹腔内损伤阴性预测值极佳,但漏诊部分有临床影响、需要额外管理的腹腔内损伤。
  • 作者建议,应联合创伤 bay 实验室检查和胸部X线来预测所有腹腔内损伤的极低风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: A clinical prediction rule has been published by the Pediatric Emergency Care Applied Research Network (PECARN) to identify children at very low risk of intra-abdominal injury requiring acute intervention (IAI-intervention) following blunt abdominal trauma in which computed tomography scan of the abdomen could be avoided. This study aims to assess the external validity of the PECARN prediction rule for IAI-intervention and determine its accuracy for identifying all patients with intra-abdominal injuries following blunt abdominal trauma, including those who did not require acute interventions.

METHODS: Data were collected prospectively from 14 trauma centers for 2,188 children younger than 16 years who presented following blunt abdominal trauma over a 1-year period. We then retrospectively applied the PECARN prediction rule to this new cohort to risk stratify the patients for intra-abdominal injury (IAI) and IAI-intervention.

RESULTS: A total of 2,188 children with a mean (SD) age of 7.8 (4.6) years were included. The PECARN prediction rule identified 60 of 62 patients with IAI-intervention with a sensitivity of 96.8%, specificity of 46.6%, and a negative predictive value (NPV) of 99.8%. The PECARN prediction rule identified 227 of 261 patients with any IAI with a sensitivity of 86.6%, specificity of 49.7%, and an NPV of 96.5%. The most missed injury by the PECARN rule was liver laceration (n = 22). In addition, 34 of 35 patients with an IAI not predicted by the PECARN rule had an abnormal laboratory value or x-ray finding.

CONCLUSION: Although the PECARN prediction rule has excellent NPV for identifying patients with intra-abdominal injuries needing an acute intervention, it fails to detect some children with clinically impactful intra-abdominal injuries that required additional management. The addition of trauma bay laboratories and chest x-ray should be used to predict patients at very low risk for all IAI.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Frederick AB, Vogel AM, Williams RF, et al. Multicenter external validation of the Pediatric Emergency Care Applied Research Network rule to identify children at very low risk for intra-abdominal injury requiring acute intervention. J Trauma Acute Care Surg. 2025. PMID: 40170217. doi:10.1097/TA.0000000000004597

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。